Characterization of prostate cancers potentially amenable to tyrosine kinase inhibitors of platelet derived growth factor receptor

被引：0
|
作者：
Fecko, A [1 ]
Shen, RL [1 ]
Chinnaiyan, AM [1 ]
Rubin, MA [1 ]
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA
来源：
LABORATORY INVESTIGATION | 2003年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
675
引用
收藏
页码：149A / 149A
页数：1
相关论文
共 50 条
  • [21] Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy
    Criscitiello, Carmen
    Gelao, Lucia
    Viale, Giulia
    Esposito, Angela
    Curigliano, Giuseppe
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 599 - 610
  • [22] The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor α
    Miyake, S
    Lupher, ML
    Druker, B
    Band, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 7927 - 7932
  • [23] Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation
    Lipson, KE
    Pang, L
    Huber, LJ
    Chen, H
    Tsai, JM
    Hirth, P
    Gazit, A
    Levitzki, A
    McMahon, G
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 285 (02): : 844 - 852
  • [24] Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers
    Fukui T.
    Mitsudomi T.
    General Thoracic and Cardiovascular Surgery, 2008, 56 (3) : 97 - 103
  • [25] Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease
    Kanaan, Rana
    Strange, Charlie
    EUROPEAN RESPIRATORY REVIEW, 2017, 26 (146):
  • [26] Pharmacogenomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
    Jimeno, Antonio
    Hidalgo, Manuel
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2006, 1766 (02): : 217 - 229
  • [27] Neuropathy with vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Roy, Bhaskar
    Das, Avash
    Ashish, Kumar
    Bandyopadhyay, Dhrubajyoti
    Maiti, Abhishek
    Chakraborty, Sandipan
    Stone, Martha E.
    Philpotts, Lisa Liang
    Nowak, Richard J.
    Patwa, Huned S.
    NEUROLOGY, 2019, 93 (02) : E143 - E148
  • [28] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Depression Reply
    Morgan, Jeffrey A.
    Quek, Richard
    George, Suzanne
    Block, Susan D.
    Demetri, George D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : E51 - E51
  • [29] Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor
    Liechti, C
    Séquin, U
    Bold, G
    Furet, P
    Meyer, T
    Traxler, P
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (01) : 11 - 26
  • [30] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Anticancer Agents
    Fortunato Ciardiello
    Drugs, 2000, 60 : 25 - 32
12345